Investor Type | Firm |
Industries | Businesses Solutions • Life Science • Oncology |
EcoR1 Capital, founded in 2012, is a specialized hedge fund based in San Francisco, California, with an additional office in Boston, Massachusetts. The firm is exclusively oriented towards the biotechnology and healthcare sectors, focusing its investments on driving forward therapeutic innovation that enhances patient care. At the heart of EcoR1 Capital's investment thesis is the commitment to fueling the science that has the potential to improve lives. They aim to foster long-term partnerships with audacious entrepreneurs who are relentlessly pursuing advancements in the development of new medicines. EcoR1 Capital is passionate about the art and the science behind biotech innovation, and they are engaged in pioneering breakthroughs by leveraging the robust substrate underpinning biological and chemical discovery. Given the exponential growth in understanding the molecular basis of disease, EcoR1 sees a clear and exhilarating roadmap for the drug hunters they partner with. The firm's team prides itself on a uniquely curious approach that often leads to asking unprecedented questions, a trait they consider a badge of honor signaling their deep involvement in both scientific discovery and strategic development. Finding hidden value is inscribed in their 'genetic code', and they actively seek this value across various arenas in the biotech field. EcoR1 Capital also distinguishes itself by supporting innovation within the realms of Business Solutions, Life Science, and Oncology, emphasizing a strategic approach tailored to the dynamic nature of these industries.